MedTrace Logo

Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial

NCT01417130 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1650

Last updated 2012-01-09

No results posted yet for this study

Summary

The Alzheimer's Disease Anti-inflammatory Prevention Trial - Follow-up Study (ADAPT-FS) will continue observations of the declared primary outcomes of the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) in the cohort previously established for that trial.

Conditions

Sponsors & Collaborators

  • VA Puget Sound Health Care System

    collaborator FED

  • National Institute on Aging (NIA)

    collaborator NIH

  • Johns Hopkins University

    collaborator OTHER

  • Seattle Institute for Biomedical and Clinical Research

    lead OTHER

Principal Investigators

  • John CS Breitner, MD, MPH · Veteran Affairs Puget Sound Health Care System

  • Laura D Baker, PhD · Veteran Affairs Puget Sound Health Care System

  • Constantine Lyketsos, MD, MHS · The Johns Hopkins University

  • Peter Zandi, PhD · The Johns Hopkins University

  • Denis Evans, MD · Rush Institute for Healthy Aging

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-10-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01417130 on ClinicalTrials.gov